These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2). Köhler SC, Wiese M. J Med Chem; 2015 May 14; 58(9):3910-21. PubMed ID: 25855895 [Abstract] [Full Text] [Related]
30. Obatoclax as a perpetrator in drug-drug interactions and its efficacy in multidrug resistance cell lines. Theile D, Allendorf D, Köhler BC, Jassowicz A, Weiss J. J Pharm Pharmacol; 2015 Nov 14; 67(11):1575-84. PubMed ID: 26255619 [Abstract] [Full Text] [Related]
34. Piperine, an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress. Yaffe PB, Power Coombs MR, Doucette CD, Walsh M, Hoskin DW. Mol Carcinog; 2015 Oct 14; 54(10):1070-85. PubMed ID: 24819444 [Abstract] [Full Text] [Related]
35. Synergistic enhancement: Exploring the potential of piperine in cancer therapeutics through chemosensitization and combination therapies. Manickasamy MK, Kumar A, BharathwajChetty B, Alqahtani MS, Abbas M, Alqahtani A, Unnikrishnan J, Bishayee A, Sethi G, Kunnumakkara AB. Life Sci; 2024 Oct 01; 354():122943. PubMed ID: 39117139 [Abstract] [Full Text] [Related]
36. In silico comparisons between natural inhibitors of ABCB1/P-glycoprotein to overcome doxorubicin-resistance in the NCI/ADR-RES cell line. Morsy MA, El-Sheikh AAK, Ibrahim ARN, Khedr MA, Al-Taher AY. Eur J Pharm Sci; 2018 Jan 15; 112():87-94. PubMed ID: 29133241 [Abstract] [Full Text] [Related]
38. Piperine as a Potential Anti-cancer Agent: A Review on Preclinical Studies. Manayi A, Nabavi SM, Setzer WN, Jafari S. Curr Med Chem; 2018 Jan 15; 25(37):4918-4928. PubMed ID: 28545378 [Abstract] [Full Text] [Related]
39. Piperine: Chemical, biological and nanotechnological applications. Quijia CR, Araujo VH, Chorilli M. Acta Pharm; 2021 Jun 01; 71(2):185-213. PubMed ID: 33151173 [Abstract] [Full Text] [Related]
40. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2. Dai CL, Liang YJ, Wang YS, Tiwari AK, Yan YY, Wang F, Chen ZS, Tong XZ, Fu LW. Cancer Lett; 2009 Jun 28; 279(1):74-83. PubMed ID: 19232821 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]